NCT02379676 - Effect of Ticagrelor Versus Clopidogrel on Endothelial Dysfunction and Vascular Inflammation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions

Endothelial DysfunctionVascular Inflammation

Interventions

DRUG

Ticagrelor

Ticagrelor 90mg twice daily for 30 days

DRUG

Clopidogrel

Clopidogrel 75mg once daily for 30 days

Trial Locations (1)

RECRUITING

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul